nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—Respiratory distress—Sorafenib—liver cancer	0.0173	0.0246	CcSEcCtD
Dorzolamide—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0151	0.0215	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Sorafenib—liver cancer	0.00878	0.0125	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Sorafenib—liver cancer	0.00843	0.012	CcSEcCtD
Dorzolamide—Cardiac failure—Sorafenib—liver cancer	0.00815	0.0116	CcSEcCtD
Dorzolamide—Pain in extremity—Sorafenib—liver cancer	0.00796	0.0113	CcSEcCtD
Dorzolamide—Mood swings—Sorafenib—liver cancer	0.00754	0.0108	CcSEcCtD
Dorzolamide—Local reaction—Epirubicin—liver cancer	0.00732	0.0104	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00717	0.0102	CcSEcCtD
Dorzolamide—Lacrimation—Epirubicin—liver cancer	0.00689	0.00983	CcSEcCtD
Dorzolamide—Local reaction—Doxorubicin—liver cancer	0.00677	0.00966	CcSEcCtD
Dorzolamide—Psoriasis—Epirubicin—liver cancer	0.00645	0.00919	CcSEcCtD
Dorzolamide—Lacrimation—Doxorubicin—liver cancer	0.00638	0.00909	CcSEcCtD
Dorzolamide—Erectile dysfunction—Sorafenib—liver cancer	0.00633	0.00903	CcSEcCtD
Dorzolamide—Keratitis—Epirubicin—liver cancer	0.00625	0.00891	CcSEcCtD
Dorzolamide—Weight decreased—Sorafenib—liver cancer	0.00622	0.00887	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00608	0.00867	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Sorafenib—liver cancer	0.00605	0.00862	CcSEcCtD
Dorzolamide—Myocardial infarction—Sorafenib—liver cancer	0.00601	0.00857	CcSEcCtD
Dorzolamide—Redness—Epirubicin—liver cancer	0.006	0.00856	CcSEcCtD
Dorzolamide—Psoriasis—Doxorubicin—liver cancer	0.00596	0.0085	CcSEcCtD
Dorzolamide—Epistaxis—Sorafenib—liver cancer	0.00578	0.00825	CcSEcCtD
Dorzolamide—Keratitis—Doxorubicin—liver cancer	0.00578	0.00824	CcSEcCtD
Dorzolamide—Hepatomegaly—Epirubicin—liver cancer	0.00572	0.00816	CcSEcCtD
Dorzolamide—Redness—Doxorubicin—liver cancer	0.00555	0.00792	CcSEcCtD
Dorzolamide—Scotoma—Epirubicin—liver cancer	0.00534	0.00761	CcSEcCtD
Dorzolamide—Hepatomegaly—Doxorubicin—liver cancer	0.0053	0.00755	CcSEcCtD
Dorzolamide—Rash erythematous—Epirubicin—liver cancer	0.00529	0.00754	CcSEcCtD
Dorzolamide—Erythema multiforme—Sorafenib—liver cancer	0.00521	0.00742	CcSEcCtD
Dorzolamide—Tinnitus—Sorafenib—liver cancer	0.00513	0.00732	CcSEcCtD
Dorzolamide—Stinging—Epirubicin—liver cancer	0.005	0.00713	CcSEcCtD
Dorzolamide—Scotoma—Doxorubicin—liver cancer	0.00494	0.00704	CcSEcCtD
Dorzolamide—Arrhythmia—Sorafenib—liver cancer	0.00492	0.00701	CcSEcCtD
Dorzolamide—Rash erythematous—Doxorubicin—liver cancer	0.0049	0.00698	CcSEcCtD
Dorzolamide—Alopecia—Sorafenib—liver cancer	0.00487	0.00694	CcSEcCtD
Dorzolamide—Erythema—Sorafenib—liver cancer	0.00479	0.00683	CcSEcCtD
Dorzolamide—Dysgeusia—Sorafenib—liver cancer	0.00469	0.00669	CcSEcCtD
Dorzolamide—Stinging—Doxorubicin—liver cancer	0.00463	0.0066	CcSEcCtD
Dorzolamide—Vasodilation procedure—Epirubicin—liver cancer	0.00461	0.00658	CcSEcCtD
Dorzolamide—Vasodilation—Epirubicin—liver cancer	0.00461	0.00658	CcSEcCtD
Dorzolamide—Lacrimation increased—Epirubicin—liver cancer	0.0044	0.00627	CcSEcCtD
Dorzolamide—Angioedema—Sorafenib—liver cancer	0.00438	0.00624	CcSEcCtD
Dorzolamide—Syncope—Sorafenib—liver cancer	0.0043	0.00613	CcSEcCtD
Dorzolamide—Vasodilation—Doxorubicin—liver cancer	0.00427	0.00608	CcSEcCtD
Dorzolamide—Vasodilation procedure—Doxorubicin—liver cancer	0.00427	0.00608	CcSEcCtD
Dorzolamide—Loss of consciousness—Sorafenib—liver cancer	0.00421	0.00601	CcSEcCtD
Dorzolamide—Cough—Sorafenib—liver cancer	0.00418	0.00596	CcSEcCtD
Dorzolamide—Atrioventricular block—Epirubicin—liver cancer	0.00418	0.00596	CcSEcCtD
Dorzolamide—Hypertension—Sorafenib—liver cancer	0.00414	0.0059	CcSEcCtD
Dorzolamide—Arthralgia—Sorafenib—liver cancer	0.00408	0.00582	CcSEcCtD
Dorzolamide—Lacrimation increased—Doxorubicin—liver cancer	0.00407	0.0058	CcSEcCtD
Dorzolamide—Dermatitis contact—Epirubicin—liver cancer	0.004	0.00571	CcSEcCtD
Dorzolamide—Abnormal dreams—Epirubicin—liver cancer	0.004	0.00571	CcSEcCtD
Dorzolamide—Dry mouth—Sorafenib—liver cancer	0.00399	0.00569	CcSEcCtD
Dorzolamide—Anaphylactic shock—Sorafenib—liver cancer	0.00391	0.00558	CcSEcCtD
Dorzolamide—Atrioventricular block—Doxorubicin—liver cancer	0.00386	0.00551	CcSEcCtD
Dorzolamide—Shock—Sorafenib—liver cancer	0.00385	0.00549	CcSEcCtD
Dorzolamide—Blood urea increased—Epirubicin—liver cancer	0.00383	0.00545	CcSEcCtD
Dorzolamide—Dry eye—Epirubicin—liver cancer	0.00374	0.00534	CcSEcCtD
Dorzolamide—Anorexia—Sorafenib—liver cancer	0.00373	0.00532	CcSEcCtD
Dorzolamide—Abnormal dreams—Doxorubicin—liver cancer	0.0037	0.00528	CcSEcCtD
Dorzolamide—Dermatitis contact—Doxorubicin—liver cancer	0.0037	0.00528	CcSEcCtD
Dorzolamide—Pulmonary oedema—Epirubicin—liver cancer	0.00361	0.00514	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00356	0.00508	CcSEcCtD
Dorzolamide—Blood urea increased—Doxorubicin—liver cancer	0.00354	0.00505	CcSEcCtD
Dorzolamide—Dyspnoea—Sorafenib—liver cancer	0.00349	0.00497	CcSEcCtD
Dorzolamide—Dry eye—Doxorubicin—liver cancer	0.00346	0.00494	CcSEcCtD
Dorzolamide—Dyspepsia—Sorafenib—liver cancer	0.00344	0.00491	CcSEcCtD
Dorzolamide—Decreased appetite—Sorafenib—liver cancer	0.0034	0.00485	CcSEcCtD
Dorzolamide—Fatigue—Sorafenib—liver cancer	0.00337	0.00481	CcSEcCtD
Dorzolamide—Pain—Sorafenib—liver cancer	0.00334	0.00477	CcSEcCtD
Dorzolamide—Pulmonary oedema—Doxorubicin—liver cancer	0.00334	0.00476	CcSEcCtD
Dorzolamide—Eye pain—Epirubicin—liver cancer	0.00326	0.00465	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Epirubicin—liver cancer	0.00324	0.00462	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Sorafenib—liver cancer	0.0032	0.00456	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Epirubicin—liver cancer	0.00312	0.00444	CcSEcCtD
Dorzolamide—Urticaria—Sorafenib—liver cancer	0.00311	0.00443	CcSEcCtD
Dorzolamide—Body temperature increased—Sorafenib—liver cancer	0.00309	0.00441	CcSEcCtD
Dorzolamide—Abdominal pain—Sorafenib—liver cancer	0.00309	0.00441	CcSEcCtD
Dorzolamide—Eye pain—Doxorubicin—liver cancer	0.00301	0.0043	CcSEcCtD
Dorzolamide—Hypoglycaemia—Epirubicin—liver cancer	0.00301	0.0043	CcSEcCtD
Dorzolamide—Cardiac failure—Epirubicin—liver cancer	0.00301	0.0043	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Epirubicin—liver cancer	0.003	0.00428	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Doxorubicin—liver cancer	0.003	0.00428	CcSEcCtD
Dorzolamide—Pain in extremity—Epirubicin—liver cancer	0.00294	0.00419	CcSEcCtD
Dorzolamide—Diplopia—Epirubicin—liver cancer	0.00294	0.00419	CcSEcCtD
Dorzolamide—Affect lability—Epirubicin—liver cancer	0.00289	0.00413	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00288	0.00411	CcSEcCtD
Dorzolamide—Hypersensitivity—Sorafenib—liver cancer	0.00288	0.00411	CcSEcCtD
Dorzolamide—Asthenia—Sorafenib—liver cancer	0.00281	0.004	CcSEcCtD
Dorzolamide—Cardiac arrest—Epirubicin—liver cancer	0.0028	0.00399	CcSEcCtD
Dorzolamide—Cardiac failure—Doxorubicin—liver cancer	0.00279	0.00398	CcSEcCtD
Dorzolamide—Hypoglycaemia—Doxorubicin—liver cancer	0.00279	0.00398	CcSEcCtD
Dorzolamide—Mood swings—Epirubicin—liver cancer	0.00279	0.00397	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Doxorubicin—liver cancer	0.00278	0.00396	CcSEcCtD
Dorzolamide—Pruritus—Sorafenib—liver cancer	0.00277	0.00395	CcSEcCtD
Dorzolamide—Diplopia—Doxorubicin—liver cancer	0.00272	0.00388	CcSEcCtD
Dorzolamide—Pain in extremity—Doxorubicin—liver cancer	0.00272	0.00388	CcSEcCtD
Dorzolamide—Affect lability—Doxorubicin—liver cancer	0.00268	0.00382	CcSEcCtD
Dorzolamide—Diarrhoea—Sorafenib—liver cancer	0.00268	0.00382	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00265	0.00378	CcSEcCtD
Dorzolamide—Cardiac arrest—Doxorubicin—liver cancer	0.00259	0.00369	CcSEcCtD
Dorzolamide—Dizziness—Sorafenib—liver cancer	0.00259	0.00369	CcSEcCtD
Dorzolamide—Mood swings—Doxorubicin—liver cancer	0.00258	0.00368	CcSEcCtD
Dorzolamide—Influenza—Epirubicin—liver cancer	0.00254	0.00362	CcSEcCtD
Dorzolamide—Vomiting—Sorafenib—liver cancer	0.00249	0.00355	CcSEcCtD
Dorzolamide—Angina pectoris—Epirubicin—liver cancer	0.00248	0.00353	CcSEcCtD
Dorzolamide—Rash—Sorafenib—liver cancer	0.00247	0.00352	CcSEcCtD
Dorzolamide—Dermatitis—Sorafenib—liver cancer	0.00246	0.00351	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00245	0.00349	CcSEcCtD
Dorzolamide—Headache—Sorafenib—liver cancer	0.00245	0.00349	CcSEcCtD
Dorzolamide—Bronchitis—Epirubicin—liver cancer	0.00244	0.00349	CcSEcCtD
Dorzolamide—Dysuria—Epirubicin—liver cancer	0.00238	0.00339	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Epirubicin—liver cancer	0.00236	0.00337	CcSEcCtD
Dorzolamide—Influenza—Doxorubicin—liver cancer	0.00235	0.00335	CcSEcCtD
Dorzolamide—Nausea—Sorafenib—liver cancer	0.00232	0.00331	CcSEcCtD
Dorzolamide—Weight decreased—Epirubicin—liver cancer	0.0023	0.00328	CcSEcCtD
Dorzolamide—Hyperglycaemia—Epirubicin—liver cancer	0.00229	0.00327	CcSEcCtD
Dorzolamide—Angina pectoris—Doxorubicin—liver cancer	0.00229	0.00327	CcSEcCtD
Dorzolamide—Bronchitis—Doxorubicin—liver cancer	0.00226	0.00323	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00225	0.0032	CcSEcCtD
Dorzolamide—Urinary tract infection—Epirubicin—liver cancer	0.0022	0.00314	CcSEcCtD
Dorzolamide—Conjunctivitis—Epirubicin—liver cancer	0.0022	0.00314	CcSEcCtD
Dorzolamide—Dysuria—Doxorubicin—liver cancer	0.0022	0.00314	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00219	0.00312	CcSEcCtD
Dorzolamide—Sweating—Epirubicin—liver cancer	0.00217	0.0031	CcSEcCtD
Dorzolamide—Epistaxis—Epirubicin—liver cancer	0.00214	0.00305	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—liver cancer	0.00213	0.00303	CcSEcCtD
Dorzolamide—Sinusitis—Epirubicin—liver cancer	0.00213	0.00303	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—liver cancer	0.00212	0.00303	CcSEcCtD
Dorzolamide—Agranulocytosis—Epirubicin—liver cancer	0.00212	0.00302	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00208	0.00296	CcSEcCtD
Dorzolamide—Bradycardia—Epirubicin—liver cancer	0.00207	0.00295	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—liver cancer	0.00204	0.00291	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—liver cancer	0.00204	0.00291	CcSEcCtD
Dorzolamide—Pharyngitis—Epirubicin—liver cancer	0.00202	0.00288	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—liver cancer	0.00201	0.00287	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—liver cancer	0.00198	0.00282	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—liver cancer	0.00197	0.00281	CcSEcCtD
Dorzolamide—Visual impairment—Epirubicin—liver cancer	0.00196	0.0028	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—liver cancer	0.00196	0.00279	CcSEcCtD
Dorzolamide—Erythema multiforme—Epirubicin—liver cancer	0.00192	0.00274	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—liver cancer	0.00192	0.00273	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—liver cancer	0.0019	0.00271	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—liver cancer	0.00187	0.00266	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—liver cancer	0.00182	0.00259	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—liver cancer	0.00181	0.00259	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—liver cancer	0.0018	0.00256	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—liver cancer	0.00178	0.00254	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—liver cancer	0.00177	0.00253	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—liver cancer	0.00176	0.0025	CcSEcCtD
Dorzolamide—Tension—Epirubicin—liver cancer	0.00174	0.00248	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—liver cancer	0.00173	0.00247	CcSEcCtD
Dorzolamide—Nervousness—Epirubicin—liver cancer	0.00172	0.00245	CcSEcCtD
Dorzolamide—Back pain—Epirubicin—liver cancer	0.00171	0.00244	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—liver cancer	0.00168	0.0024	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—liver cancer	0.00167	0.00238	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—liver cancer	0.00166	0.00237	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—liver cancer	0.00164	0.00234	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—liver cancer	0.00161	0.00229	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—liver cancer	0.0016	0.00229	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—liver cancer	0.00159	0.00227	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—liver cancer	0.00159	0.00227	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—liver cancer	0.00159	0.00226	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—liver cancer	0.00159	0.00226	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—liver cancer	0.00157	0.00223	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—liver cancer	0.00156	0.00222	CcSEcCtD
Dorzolamide—Cough—Epirubicin—liver cancer	0.00155	0.0022	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—liver cancer	0.00154	0.0022	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—liver cancer	0.00153	0.00218	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—liver cancer	0.00151	0.00215	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—liver cancer	0.00151	0.00215	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—liver cancer	0.0015	0.00214	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—liver cancer	0.00149	0.00212	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—liver cancer	0.00147	0.0021	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—liver cancer	0.00147	0.0021	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—liver cancer	0.00147	0.0021	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—liver cancer	0.00146	0.00208	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—liver cancer	0.00145	0.00207	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—liver cancer	0.00145	0.00206	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—liver cancer	0.00145	0.00206	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—liver cancer	0.00144	0.00205	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—liver cancer	0.00143	0.00204	CcSEcCtD
Dorzolamide—Shock—Epirubicin—liver cancer	0.00142	0.00203	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—liver cancer	0.00141	0.00202	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—liver cancer	0.0014	0.00199	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—liver cancer	0.0014	0.00199	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—liver cancer	0.0014	0.00199	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—liver cancer	0.00139	0.00198	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—liver cancer	0.00138	0.00197	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—liver cancer	0.00138	0.00196	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—liver cancer	0.00136	0.00195	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—liver cancer	0.00135	0.00193	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—liver cancer	0.00135	0.00192	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—liver cancer	0.00134	0.00191	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—liver cancer	0.00134	0.00191	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00132	0.00188	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—liver cancer	0.00132	0.00188	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—liver cancer	0.00131	0.00186	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—liver cancer	0.0013	0.00185	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—liver cancer	0.00129	0.00184	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—liver cancer	0.00129	0.00184	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—liver cancer	0.00129	0.00183	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—liver cancer	0.00127	0.00182	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—liver cancer	0.00127	0.00181	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—liver cancer	0.00126	0.00179	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—liver cancer	0.00125	0.00178	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—liver cancer	0.00125	0.00178	CcSEcCtD
Dorzolamide—Pain—Epirubicin—liver cancer	0.00124	0.00176	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00122	0.00174	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—liver cancer	0.00121	0.00173	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—liver cancer	0.0012	0.00171	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—liver cancer	0.00119	0.0017	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—liver cancer	0.00119	0.0017	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—liver cancer	0.00119	0.0017	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—liver cancer	0.00118	0.00169	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—liver cancer	0.00118	0.00168	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—liver cancer	0.00116	0.00166	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—liver cancer	0.00115	0.00164	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—liver cancer	0.00115	0.00164	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—liver cancer	0.00114	0.00163	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—liver cancer	0.00114	0.00163	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—liver cancer	0.00114	0.00163	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—liver cancer	0.0011	0.00157	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—liver cancer	0.00109	0.00156	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—liver cancer	0.00107	0.00152	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—liver cancer	0.00106	0.00152	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—liver cancer	0.00106	0.00151	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—liver cancer	0.00106	0.00151	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—liver cancer	0.00104	0.00148	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—liver cancer	0.00102	0.00146	CcSEcCtD
Dorzolamide—Diarrhoea—Epirubicin—liver cancer	0.000989	0.00141	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—liver cancer	0.000985	0.00141	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—liver cancer	0.00096	0.00137	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—liver cancer	0.000956	0.00136	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—liver cancer	0.000946	0.00135	CcSEcCtD
Dorzolamide—Vomiting—Epirubicin—liver cancer	0.000919	0.00131	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—liver cancer	0.000915	0.0013	CcSEcCtD
Dorzolamide—Rash—Epirubicin—liver cancer	0.000911	0.0013	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—liver cancer	0.000911	0.0013	CcSEcCtD
Dorzolamide—Headache—Epirubicin—liver cancer	0.000906	0.00129	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—liver cancer	0.000884	0.00126	CcSEcCtD
Dorzolamide—Nausea—Epirubicin—liver cancer	0.000859	0.00122	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—liver cancer	0.00085	0.00121	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—liver cancer	0.000843	0.0012	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—liver cancer	0.000843	0.0012	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—liver cancer	0.000838	0.00119	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—liver cancer	0.000794	0.00113	CcSEcCtD
Dorzolamide—CA5B—Metabolism—HMOX1—liver cancer	0.000315	0.00105	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GSTM1—liver cancer	0.000314	0.00105	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GSTM1—liver cancer	0.000314	0.00105	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PSMA4—liver cancer	0.000313	0.00105	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PSMD10—liver cancer	0.000313	0.00105	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000308	0.00103	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CYP1A1—liver cancer	0.000306	0.00102	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GOT2—liver cancer	0.000304	0.00102	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PSMA4—liver cancer	0.0003	0.001	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PSMD10—liver cancer	0.0003	0.001	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP1A1—liver cancer	0.000298	0.000998	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP1A1—liver cancer	0.000298	0.000998	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GSTP1—liver cancer	0.000296	0.00099	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GSTM1—liver cancer	0.000293	0.000982	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GSTM1—liver cancer	0.000293	0.000982	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000293	0.00098	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—HMOX1—liver cancer	0.000292	0.000977	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GOT2—liver cancer	0.000292	0.000977	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PSMA4—liver cancer	0.000288	0.000962	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PSMD10—liver cancer	0.000288	0.000962	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP2E1—liver cancer	0.000286	0.000958	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—MTHFR—liver cancer	0.000285	0.000954	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.000285	0.000953	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—HPGDS—liver cancer	0.000284	0.000949	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.000281	0.00094	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GOT2—liver cancer	0.00028	0.000936	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PPARA—liver cancer	0.00028	0.000936	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000279	0.000934	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CYP1A1—liver cancer	0.000278	0.000931	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP1A1—liver cancer	0.000278	0.000931	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—MTHFR—liver cancer	0.000278	0.00093	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—MTHFR—liver cancer	0.000278	0.00093	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP2E1—liver cancer	0.000274	0.000918	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PPARA—liver cancer	0.000273	0.000912	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PPARA—liver cancer	0.000273	0.000912	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GSTM1—liver cancer	0.000272	0.00091	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYCS—liver cancer	0.000268	0.000896	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP2E1—liver cancer	0.000263	0.00088	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GOT1—liver cancer	0.000263	0.000879	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GGT1—liver cancer	0.000263	0.000879	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.000261	0.000875	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—MTHFR—liver cancer	0.000259	0.000868	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—MTHFR—liver cancer	0.000259	0.000868	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.000258	0.000863	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP1A1—liver cancer	0.000258	0.000863	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYCS—liver cancer	0.000257	0.000859	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PPARA—liver cancer	0.000254	0.000852	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PPARA—liver cancer	0.000254	0.000852	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PSMD10—liver cancer	0.000253	0.000846	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PSMA4—liver cancer	0.000253	0.000846	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000252	0.000844	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GGT1—liver cancer	0.000252	0.000843	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GOT1—liver cancer	0.000252	0.000843	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.000248	0.00083	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYCS—liver cancer	0.000246	0.000824	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GOT2—liver cancer	0.000246	0.000823	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	0.000244	0.000818	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—TP53—liver cancer	0.000244	0.000817	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000243	0.000814	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GOT1—liver cancer	0.000241	0.000808	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GGT1—liver cancer	0.000241	0.000808	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—MTHFR—liver cancer	0.00024	0.000804	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CG—liver cancer	0.00024	0.000802	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTP1—liver cancer	0.000236	0.00079	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PPARA—liver cancer	0.000236	0.000789	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CG—liver cancer	0.000233	0.000781	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CG—liver cancer	0.000233	0.000781	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—HMOX1—liver cancer	0.000233	0.000779	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP2E1—liver cancer	0.000231	0.000774	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PPARG—liver cancer	0.000231	0.000774	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000228	0.000762	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTP1—liver cancer	0.000226	0.000757	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PPARG—liver cancer	0.000225	0.000754	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PPARG—liver cancer	0.000225	0.000754	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000224	0.000751	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—IL6—liver cancer	0.000223	0.000748	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—HMOX1—liver cancer	0.000223	0.000747	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CG—liver cancer	0.000218	0.000729	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CG—liver cancer	0.000218	0.000729	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTP1—liver cancer	0.000217	0.000726	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTM1—liver cancer	0.000217	0.000726	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYCS—liver cancer	0.000216	0.000724	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—HMOX1—liver cancer	0.000214	0.000716	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GGT1—liver cancer	0.000212	0.00071	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GOT1—liver cancer	0.000212	0.00071	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CD—liver cancer	0.000211	0.000705	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PPARG—liver cancer	0.00021	0.000704	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PPARG—liver cancer	0.00021	0.000704	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000209	0.000699	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTM1—liver cancer	0.000208	0.000696	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ALB—liver cancer	0.000208	0.000696	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP1A1—liver cancer	0.000206	0.000688	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CD—liver cancer	0.000205	0.000687	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CD—liver cancer	0.000205	0.000687	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ALB—liver cancer	0.000203	0.000678	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ALB—liver cancer	0.000203	0.000678	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CG—liver cancer	0.000202	0.000676	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTM1—liver cancer	0.000199	0.000667	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP1A1—liver cancer	0.000197	0.00066	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PPARG—liver cancer	0.000195	0.000652	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—MTHFR—liver cancer	0.000192	0.000641	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CD—liver cancer	0.000192	0.000641	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CD—liver cancer	0.000192	0.000641	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTP1—liver cancer	0.000191	0.000638	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ALB—liver cancer	0.000189	0.000633	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ALB—liver cancer	0.000189	0.000633	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP1A1—liver cancer	0.000189	0.000632	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—HMOX1—liver cancer	0.000188	0.000629	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PPARA—liver cancer	0.000188	0.000629	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000188	0.000628	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000186	0.000622	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—UGDH—liver cancer	0.000185	0.000621	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000185	0.00062	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—MTHFR—liver cancer	0.000184	0.000615	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CB—liver cancer	0.000184	0.000614	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PPARA—liver cancer	0.00018	0.000603	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CB—liver cancer	0.000179	0.000599	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CB—liver cancer	0.000179	0.000599	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CD—liver cancer	0.000177	0.000594	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—MTHFR—liver cancer	0.000176	0.00059	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTM1—liver cancer	0.000175	0.000586	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ALB—liver cancer	0.000175	0.000586	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—EPT1—liver cancer	0.000174	0.000584	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARA—liver cancer	0.000173	0.000578	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000172	0.000577	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.00017	0.000569	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CB—liver cancer	0.000167	0.000559	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CB—liver cancer	0.000167	0.000559	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP1A1—liver cancer	0.000166	0.000556	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TAT—liver cancer	0.000165	0.000553	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000163	0.000547	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000163	0.000544	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000161	0.00054	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CG—liver cancer	0.000161	0.000539	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PPARG—liver cancer	0.000155	0.00052	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MTHFR—liver cancer	0.000155	0.000518	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CB—liver cancer	0.000155	0.000518	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CG—liver cancer	0.000154	0.000517	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARA—liver cancer	0.000152	0.000508	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PPARG—liver cancer	0.000149	0.000499	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CG—liver cancer	0.000148	0.000495	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARG—liver cancer	0.000143	0.000478	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CD—liver cancer	0.000142	0.000474	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALB—liver cancer	0.00014	0.000468	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CD—liver cancer	0.000136	0.000454	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALB—liver cancer	0.000134	0.000448	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CG—liver cancer	0.00013	0.000435	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CD—liver cancer	0.00013	0.000435	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALB—liver cancer	0.000128	0.00043	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARG—liver cancer	0.000126	0.00042	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CB—liver cancer	0.000123	0.000413	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UGDH—liver cancer	0.000122	0.000409	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000122	0.000407	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CB—liver cancer	0.000118	0.000396	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—EPT1—liver cancer	0.000115	0.000385	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CD—liver cancer	0.000114	0.000383	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CB—liver cancer	0.000113	0.00038	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALB—liver cancer	0.000113	0.000378	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CPT1B—liver cancer	0.000112	0.000376	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GLUL—liver cancer	0.000112	0.000376	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CA—liver cancer	0.000112	0.000375	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CA—liver cancer	0.000109	0.000365	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CA—liver cancer	0.000109	0.000365	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TAT—liver cancer	0.000109	0.000365	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NR1H4—liver cancer	0.000108	0.000363	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA3—liver cancer	0.000106	0.000356	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CA—liver cancer	0.000102	0.000341	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CA—liver cancer	0.000102	0.000341	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CB—liver cancer	9.97e-05	0.000334	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA4—liver cancer	9.74e-05	0.000326	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	9.52e-05	0.000319	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA2—liver cancer	9.49e-05	0.000318	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CA—liver cancer	9.43e-05	0.000316	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA1—liver cancer	9.16e-05	0.000307	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AKT1—liver cancer	9.14e-05	0.000306	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NAT2—liver cancer	9.05e-05	0.000303	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AKT1—liver cancer	8.91e-05	0.000298	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AKT1—liver cancer	8.91e-05	0.000298	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	8.71e-05	0.000291	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDOB—liver cancer	8.68e-05	0.000291	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AKT1—liver cancer	8.32e-05	0.000278	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AKT1—liver cancer	8.32e-05	0.000278	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CRABP1—liver cancer	8.28e-05	0.000277	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKT1—liver cancer	7.7e-05	0.000258	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CA—liver cancer	7.52e-05	0.000252	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.46e-05	0.00025	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CPT1B—liver cancer	7.41e-05	0.000248	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GLUL—liver cancer	7.41e-05	0.000248	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HPGDS—liver cancer	7.24e-05	0.000242	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CA—liver cancer	7.21e-05	0.000241	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.2e-05	0.000241	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NR1H4—liver cancer	7.14e-05	0.000239	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA3—liver cancer	7.02e-05	0.000235	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CA—liver cancer	6.91e-05	0.000231	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.55e-05	0.000219	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.47e-05	0.000217	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PSMA4—liver cancer	6.45e-05	0.000216	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PSMD10—liver cancer	6.45e-05	0.000216	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA4—liver cancer	6.42e-05	0.000215	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GOT2—liver cancer	6.28e-05	0.00021	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA2—liver cancer	6.26e-05	0.00021	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKT1—liver cancer	6.14e-05	0.000206	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CA—liver cancer	6.08e-05	0.000203	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA1—liver cancer	6.04e-05	0.000202	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NAT2—liver cancer	5.97e-05	0.0002	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2E1—liver cancer	5.9e-05	0.000198	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKT1—liver cancer	5.89e-05	0.000197	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDOB—liver cancer	5.73e-05	0.000192	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.71e-05	0.000191	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKT1—liver cancer	5.65e-05	0.000189	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYCS—liver cancer	5.52e-05	0.000185	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CRABP1—liver cancer	5.46e-05	0.000183	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GGT1—liver cancer	5.42e-05	0.000181	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GOT1—liver cancer	5.42e-05	0.000181	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKT1—liver cancer	4.96e-05	0.000166	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTP1—liver cancer	4.87e-05	0.000163	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMOX1—liver cancer	4.8e-05	0.000161	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HPGDS—liver cancer	4.77e-05	0.00016	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM1—liver cancer	4.47e-05	0.00015	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSMD10—liver cancer	4.25e-05	0.000142	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSMA4—liver cancer	4.25e-05	0.000142	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1A1—liver cancer	4.24e-05	0.000142	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GOT2—liver cancer	4.14e-05	0.000139	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—liver cancer	3.95e-05	0.000132	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2E1—liver cancer	3.89e-05	0.00013	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARA—liver cancer	3.88e-05	0.00013	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYCS—liver cancer	3.64e-05	0.000122	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GGT1—liver cancer	3.57e-05	0.00012	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GOT1—liver cancer	3.57e-05	0.00012	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.48e-05	0.000117	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CG—liver cancer	3.32e-05	0.000111	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTP1—liver cancer	3.21e-05	0.000107	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARG—liver cancer	3.2e-05	0.000107	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMOX1—liver cancer	3.17e-05	0.000106	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM1—liver cancer	2.95e-05	9.87e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CD—liver cancer	2.92e-05	9.77e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALB—liver cancer	2.88e-05	9.65e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1A1—liver cancer	2.8e-05	9.36e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—liver cancer	2.61e-05	8.73e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARA—liver cancer	2.56e-05	8.56e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CB—liver cancer	2.54e-05	8.52e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CG—liver cancer	2.19e-05	7.33e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARG—liver cancer	2.11e-05	7.08e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CD—liver cancer	1.93e-05	6.44e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALB—liver cancer	1.9e-05	6.36e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CB—liver cancer	1.68e-05	5.62e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CA—liver cancer	1.55e-05	5.19e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKT1—liver cancer	1.27e-05	4.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CA—liver cancer	1.02e-05	3.42e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKT1—liver cancer	8.36e-06	2.8e-05	CbGpPWpGaD
